-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$400.0090809.09% Upside
SQZ Biotechnologies Company Frequently Asked Questions
-
What analysts cover SQZ Biotechnologies Company?
SQZ Biotechnologies Company has been rated by research analysts at Chardan Capital in the past 90 days.